Jeffrey M. Dayno's most recent trade in Harmony Biosciences Holdings Inc was a trade of 180,000 Stock Option done . Disclosure was reported to the exchange on Jan. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 180,000 | 180,000 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 52,000 | 52,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 10,500 | 10,500 | - | 0 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 10,500 | 31,500 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.01 per share. | 24 Jan 2025 | 4,567 | 5,933 | - | 38.0 | 173,592 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Sale of securities on an exchange or to another person at price $ 40.13 per share. | 21 Jan 2025 | 19,293 | 0 | - | 40.1 | 774,245 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 21 Jan 2025 | 19,293 | 19,293 | - | 8.2 | 158,588 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2025 | 9,737 | 2,435 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2025 | 6,086 | 0 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2025 | 3,470 | 20,000 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 202,250 | 202,250 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 42,000 | 42,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 125,000 | 125,000 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.02 per share. | 03 Nov 2022 | 15,000 | 0 | - | 60.0 | 900,332 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 15,000 | 23,470 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 03 Nov 2022 | 15,000 | 15,000 | - | 8.2 | 123,300 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 55.10 per share. | 01 Nov 2022 | 15,000 | 0 | - | 55.1 | 826,559 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 15,000 | 38,470 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 01 Nov 2022 | 15,000 | 15,000 | - | 8.2 | 123,300 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 19 Oct 2021 | 14,099 | 14,099 | - | 8.2 | 115,894 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 14,099 | 57,570 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 43.13 per share. | 19 Oct 2021 | 14,099 | 0 | - | 43.1 | 608,036 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 4,101 | 53,469 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 43.77 per share. | 19 Oct 2021 | 4,101 | 0 | - | 43.8 | 179,507 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 19 Oct 2021 | 4,101 | 4,101 | - | 8.2 | 33,710 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 06 Oct 2021 | 1,800 | 1,800 | - | 8.2 | 14,796 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 1,800 | 71,669 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.10 per share. | 06 Oct 2021 | 1,800 | 0 | - | 40.1 | 72,179 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 07 Sep 2021 | 10,000 | 10,000 | - | 8.2 | 82,200 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.58 per share. | 07 Sep 2021 | 10,000 | 0 | - | 37.6 | 375,783 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 10,000 | 73,469 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 26 Aug 2021 | 7,841 | 7,841 | - | 8.2 | 64,453 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2021 | 7,841 | 83,469 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.16 per share. | 26 Aug 2021 | 7,841 | 0 | - | 35.2 | 275,701 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 26 Aug 2021 | 2,159 | 2,159 | - | 8.2 | 17,747 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 26 Aug 2021 | 2,159 | 0 | - | 35.0 | 75,581 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2021 | 2,159 | 91,310 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 10 Aug 2021 | 9,950 | 0 | - | 30.2 | 300,634 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 9,950 | 93,469 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 10 Aug 2021 | 9,950 | 9,950 | - | 8.2 | 81,789 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Jul 2021 | 50 | 0 | - | 30 | 1,500 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2021 | 50 | 103,419 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey M. Dayno | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 22 Jul 2021 | 50 | 50 | - | 8.2 | 411 | Common Stock |